144 related articles for article (PubMed ID: 28115280)
1. Sclerostin: From bedside to bench, and back to bedside.
Robling AG; Drake MT; Papapoulos SE
Bone; 2017 Mar; 96():1-2. PubMed ID: 28115280
[No Abstract] [Full Text] [Related]
2. A Novel Domain-Specific Mutation in a Sclerosteosis Patient Suggests a Role of LRP4 as an Anchor for Sclerostin in Human Bone.
Fijalkowski I; Geets E; Steenackers E; Van Hoof V; Ramos FJ; Mortier G; Fortuna AM; Van Hul W; Boudin E
J Bone Miner Res; 2016 Apr; 31(4):874-81. PubMed ID: 26751728
[TBL] [Abstract][Full Text] [Related]
3. Sclerostin: recent advances and clinical implications.
Honasoge M; Rao AD; Rao SD
Curr Opin Endocrinol Diabetes Obes; 2014 Dec; 21(6):437-46. PubMed ID: 25333305
[TBL] [Abstract][Full Text] [Related]
4. Sclerostin: how human mutations have helped reveal a new target for the treatment of osteoporosis.
Robinson MK; Caminis J; Brunkow ME
Drug Discov Today; 2013 Jul; 18(13-14):637-43. PubMed ID: 23579167
[TBL] [Abstract][Full Text] [Related]
5. Targeting sclerostin as potential treatment of osteoporosis.
Papapoulos SE
Ann Rheum Dis; 2011 Mar; 70 Suppl 1():i119-22. PubMed ID: 21339215
[TBL] [Abstract][Full Text] [Related]
6. A Novel Mutation in a Gene Causes Sclerosteosis in a Family of Mediterranean Origin.
Ekhzaimy AA; Alyusuf EY; Alswailem M; Alzahrani AS
Medicina (Kaunas); 2022 Jan; 58(2):. PubMed ID: 35208525
[No Abstract] [Full Text] [Related]
7. The Lrp4R1170Q Homozygous Knock-In Mouse Recapitulates the Bone Phenotype of Sclerosteosis in Humans.
Boudin E; Yorgan T; Fijalkowski I; Sonntag S; Steenackers E; Hendrickx G; Peeters S; De Maré A; Vervaet B; Verhulst A; Mortier G; D'Haese P; Schinke T; Van Hul W
J Bone Miner Res; 2017 Aug; 32(8):1739-1749. PubMed ID: 28477420
[TBL] [Abstract][Full Text] [Related]
8. BMP signaling in development and diseases: a pharmacological perspective.
Bandyopadhyay A; Yadav PS; Prashar P
Biochem Pharmacol; 2013 Apr; 85(7):857-64. PubMed ID: 23333766
[TBL] [Abstract][Full Text] [Related]
9. First missense mutation in the SOST gene causing sclerosteosis by loss of sclerostin function.
Piters E; Culha C; Moester M; Van Bezooijen R; Adriaensen D; Mueller T; Weidauer S; Jennes K; de Freitas F; Löwik C; Timmermans JP; Van Hul W; Papapoulos S
Hum Mutat; 2010 Jul; 31(7):E1526-43. PubMed ID: 20583295
[TBL] [Abstract][Full Text] [Related]
10. Novel SOST gene mutation in a sclerosteosis patient from Morocco: a case report.
Belkhribchia MR; Collet C; Laplanche JL; Hassani R
Eur J Med Genet; 2014 Mar; 57(4):133-7. PubMed ID: 24594238
[TBL] [Abstract][Full Text] [Related]
11. The sclerostin story: from human genetics to the development of novel anabolic treatment for osteoporosis.
Yavropoulou MP; Xygonakis C; Lolou M; Karadimou F; Yovos JG
Hormones (Athens); 2014; 13(4):323-37. PubMed ID: 25555179
[TBL] [Abstract][Full Text] [Related]
12. Novel SOST gene mutation in a sclerosteosis patient and her parents.
Bhadada SK; Rastogi A; Steenackers E; Boudin E; Arya A; Dhiman V; Bhansali A; Van Hul W
Bone; 2013 Feb; 52(2):707-10. PubMed ID: 23079137
[TBL] [Abstract][Full Text] [Related]
13. A Novel Loss-of-Sclerostin Function Mutation in a First Egyptian Family with Sclerosteosis.
Fayez A; Aglan M; Esmaiel N; El Zanaty T; Abdel Kader M; El Ruby M
Biomed Res Int; 2015; 2015():517815. PubMed ID: 25984533
[TBL] [Abstract][Full Text] [Related]
14. Activating the unfolded protein response in osteocytes causes hyperostosis consistent with craniodiaphyseal dysplasia.
Chan WCW; Tsang KY; Cheng YW; Ng VCW; Chik H; Tan ZJ; Boot-Handford R; Boyde A; Cheung KMC; Cheah KSE; Chan D
Hum Mol Genet; 2017 Dec; 26(23):4572-4587. PubMed ID: 28973168
[TBL] [Abstract][Full Text] [Related]
15. SOST/sclerostin, an osteocyte-derived negative regulator of bone formation.
van Bezooijen RL; ten Dijke P; Papapoulos SE; Löwik CW
Cytokine Growth Factor Rev; 2005 Jun; 16(3):319-27. PubMed ID: 15869900
[TBL] [Abstract][Full Text] [Related]
16. Patients with sclerosteosis and disease carriers: human models of the effect of sclerostin on bone turnover.
van Lierop AH; Hamdy NA; Hamersma H; van Bezooijen RL; Power J; Loveridge N; Papapoulos SE
J Bone Miner Res; 2011 Dec; 26(12):2804-11. PubMed ID: 21786318
[TBL] [Abstract][Full Text] [Related]
17. Sclerosteosis caused by a novel nonsense mutation of SOST in a consanguineous family.
He WT; Chen C; Pan C; Zhang MX; Yu XF; Wang DW; Hu SH
Clin Genet; 2016 Feb; 89(2):205-9. PubMed ID: 26283468
[TBL] [Abstract][Full Text] [Related]
18. Sclerostin deficiency in humans.
van Lierop AH; Appelman-Dijkstra NM; Papapoulos SE
Bone; 2017 Mar; 96():51-62. PubMed ID: 27742500
[TBL] [Abstract][Full Text] [Related]
19. Sclerostin deficiency is linked to altered bone composition.
Hassler N; Roschger A; Gamsjaeger S; Kramer I; Lueger S; van Lierop A; Roschger P; Klaushofer K; Paschalis EP; Kneissel M; Papapoulos S
J Bone Miner Res; 2014 Oct; 29(10):2144-51. PubMed ID: 24753092
[TBL] [Abstract][Full Text] [Related]
20. The natural history of sclerosteosis.
Hamersma H; Gardner J; Beighton P
Clin Genet; 2003 Mar; 63(3):192-7. PubMed ID: 12694228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]